Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK ZWAANTJE from Antwerpen, company number BE0524805335, closed financial year 2025 with a result of € -13,589 after tax. For that financial year APOTHEEK ZWAANTJE recorded a gross margin of € 32,160 and equity of € 44,525. Compared with financial year 2024, the result moved from € 26,489 to € -13,589. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 44,525
▼ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,589
▼ still € 26,489 profit in 2024
Profit after tax over the fiscal year.
€ 2,086
▲ 98% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 4,525.
Debts at end 2025
€ 169,168
▼ 36% vs 2024
€ 21,445 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 103,034
▼ 56% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 326
▼ 72% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 97,635 | € 50,849 | € 76,145 | € 32,160 | ▼ 58% |
| Profit after taxes | € 361 | € -8,168 | € 26,489 | € -13,589 | ▼ € 40,078 |
| Equity | € 58,793 | € 50,625 | € 58,114 | € 44,525 | ▼ 23% |
| Total debts | € 768,749 | € 774,333 | € 706,239 | € 434,935 | ▼ 38% |
| Cash | € 86,483 | € 112,351 | € 1,055 | € 2,086 | ▲ 98% |
| Land & buildings | € 308,139 | € 292,922 | € 277,706 | € 262,489 | ▼ 5% |
| Retained profit | € 18,793 | € 10,625 | € 18,114 | € 4,525 | ▼ 75% |
| Dividend | € 0 | € 0 | € 19,000 | € 0 | ▼ 100% |
| Bank debt | € 423,896 | € 358,440 | € 266,170 | € 169,168 | ▼ 36% |
| Balance sheet total | € 827,541 | € 824,957 | € 764,353 | € 479,460 | ▼ 37% |
Key figures of APOTHEEK ZWAANTJE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK ZWAANTJE?
What happened at APOTHEEK ZWAANTJE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 13,589 (▼ € 40,078 vs 2024). Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 361 profit in 2022 to € 13,589 loss in 2025.
Paid € 255 in corporate taxes since 2022.
Best year ever: 2024, with € 26,489 profit.
Paid out € 19,000 in dividends to the owners in total.
A new publication or filing at APOTHEEK ZWAANTJE? We notify you, reason included.
Follow APOTHEEK ZWAANTJEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of E-pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK ZWAANTJEBehind APOTHEEK ZWAANTJE is E-pharma BV. The shares are held by E-pharma (100%).
Directors
According to the 2025 annual accounts
Director · represented by Marleen Slaets
Also active at: Apotheek De Voogt, Apotheek Cauwenbergh
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Bernardsesteenweg 357
2660 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0524.805.335
- VAT number
- BE 0524.805.335
- Registered office
- Sint-Bernardsesteenweg 357, 2660 Antwerpen
- Names & denominations
- APOTHEEK ZWAANTJE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 2013
- Peppol
- Active · Active since 21 Mar 2025
- Activities · NACE
Detailhandel in farmaceutische producten